Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 19/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13005310 | 1.00 | DPP4 (0.46) | DPP4DPP7DPP8DPP9ALDH1A1 | |
| SCHEMBL22950650 | 1.00 | DPP4 (0.46) | DPP4DPP7DPP8DPP9ALDH1A1 | |
| SCHEMBL13976147 | 0.88 | DPP4 (0.46) | DPP4DPP7ALDH1A1MAPTHTT | |
| SCHEMBL13084119 | 0.87 | DPP4 (0.45) | DPP4DPP7DPP8DPP9ALDH1A1 | |
| SCHEMBL12971210 | 0.85 | DPP4 (0.44) | DPP4DPP7DPP8DPP9 | |
| SCHEMBL30136577 | 0.85 | DPP4 (0.44) | DPP4DPP7DPP8DPP9 | |
| SCHEMBL17227455 | 0.85 | DPP4 (0.44) | DPP4DPP7 | |
| SCHEMBL2572967 | 0.85 | DPP4 (0.44) | DPP4DPP7DPP8DPP9 | |
| SCHEMBL743044 | 0.84 | DPP4 (0.42) | DPP4DPP7DPP8DPP9 | |
| SCHEMBL16750215 | 0.84 | DPP4 (0.42) | DPP4DPP7DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142248-A1 | METHOD FOR RACEMIC PREPARATION OF CHIRAL B-AMINO ACIDS AND DERIVATIVES THEREOF | ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| WO-2021017645-A1 | RACEMIC PREPARATION METHOD FOR CHIRAL β-AMINO ACID AND DERIVATIVE THEREOF | 浙江九洲药业股份有限公司 | 2021-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142248-A1 | METHOD FOR RACEMIC PREPARATION OF CHIRAL B-AMINO ACIDS AND DERIVATIVES THEREOF | GLP1R, SRR, GIPR | DPP4 7/4885DPP7 12/4885DPP8 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.